Dr. Authier obtained a doctor in veterinary medicine degree from the University of Montreal and specialized in non-clinical studies after completing a Ph.D in preclinical pharmacology. He then completed an MBA in corporate finances and management. Over the past years, Dr. Authier investigated methodologies in non-clinical regulatory safety assessment with the objective of improving study designs for optimal sensitivity and decision making in this field. Dr. Authier overviews the work of a team of scientists and veterinarians specialized preclinical research. He participated in face-to-face FDA pre-IND meetings and overviewed conduct of preclinical studies for several small and large molecules over the last 25 years working at Charles River. Dr. Authier has authored +140 peer reviewed articles and book chapters on preclinical models. To date, Dr. Authier has provided scientific overview for more than 1400 non-clinical studies covering a broad range of therapeutic indications and molecule classes.
Simon Authier, D.V.M., M.Sc., M.B.A., Ph.D., D.S.P.
Principal Director, Toxicology and Veterinary Medical Services